Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1913 3
1991 4
1992 1
1993 1
1994 4
1995 3
1996 4
1997 4
1998 5
1999 1
2000 2
2001 2
2003 1
2004 2
2005 2
2006 1
2007 1
2008 2
2009 1
2011 1
2017 1
2018 3
2019 1
2020 2
2021 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Hypertension after renal transplantation.
First MR, Neylan JF, Rocher LL, Tejani A. First MR, et al. Among authors: neylan jf. J Am Soc Nephrol. 1994 Feb;4(8 Suppl):S30-6. doi: 10.1681/ASN.V48s30. J Am Soc Nephrol. 1994. PMID: 8193293 Review.
Microchimerism and rejection in clinical transplantation.
Elwood ET, Larsen CP, Maurer DH, Routenberg KL, Neylan JF, Whelchel JD, O'Brien DP, Pearson TC. Elwood ET, et al. Among authors: neylan jf. Lancet. 1997 May 10;349(9062):1358-60. doi: 10.1016/s0140-6736(96)09105-2. Lancet. 1997. PMID: 9149698
Supplemental Report.
Neylan JF. Neylan JF. Cal State J Med. 1913 Feb;11(2):93. Cal State J Med. 1913. PMID: 18735850 Free PMC article. No abstract available.
Biotech leaders call for free press.
Cohen R, Holtzman S, Levin JM, Maraganore JM; Signatories to the Statement. Cohen R, et al. Nat Biotechnol. 2018 Oct 11;36(10):920-922. doi: 10.1038/nbt.4271. Nat Biotechnol. 2018. PMID: 30307914 No abstract available.
Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.
Gaber AO, First MR, Tesi RJ, Gaston RS, Mendez R, Mulloy LL, Light JA, Gaber LW, Squiers E, Taylor RJ, Neylan JF, Steiner RW, Knechtle S, Norman DJ, Shihab F, Basadonna G, Brennan DC, Hodge EE, Kahan BD, Kahan L, Steinberg S, Woodle ES, Chan L, Ham JM, Schroeder TJ, et al. Gaber AO, et al. Among authors: neylan jf. Transplantation. 1998 Jul 15;66(1):29-37. doi: 10.1097/00007890-199807150-00005. Transplantation. 1998. PMID: 9679818 Clinical Trial.
52 results